RVT-TFs-G is supported as a promising topical RVT delivery platform with enhanced ex vivo skin permeation and acceptable physicochemical and dermal compatibility and direct antileishmanial efficacy and skin-retention studies are required before its therapeutic applicability in CL can be established.
A. Marne, Ujwal Havelikar, S. Nangare et al.· Journal of Pharmaceutical In...· 0 citations
EASD could serve as a desirable carrier to provoke the biopharmaceutical and pharmacokinetic properties of ITZ and suggested that EASD could serve as a desirable carrier to provoke the biopharmaceutical and pharmacokinetic properties of ITZ.
D. Telange, A. Warokar, Ayush R. Mundada et al.· Journal of Pharmaceutical In...· 0 citations
This review provides a critical chemistry-to-clinical perspective on smart wearable biosensors and outlines the validation, manufacturing, cybersecurity, post-market surveillance and benchmarking requirements needed for their translation into reliable diagnostic and therapeutic-monitoring technologies.
Yachana Misha, Radheshyam Jena, Aman Shukla et al.· RSC Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.